Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's sickness.At precisely the same meeting, write-up hoc analyses from Clarity's tau-PET substudy indicated that, amongst participants who started the analyze with lower tau tangle load, far